AIA Hosts Healthcare Financing Summit To Foster Cross-Sector Collaborative Solutions for Hong Kong's Healthcare Sustainable Future
The event featured distinguished speakers, including Professor Chung-mau Lo, Secretary for Health of the Hong Kong Special Administrative Region Government, and Mr Clement Cheung Wan-ching, Chief Executive Officer of the Insurance Authority, who shared their insights on the future of Hong Kong's healthcare. Discussions focused on the growing challenges of rising healthcare costs, an ageing population, the critical needs to foster price transparency and budgeting for patients, clinical governance in private medical services, and how stakeholders can work together to ensure the long-term sustainability of Hong Kong's healthcare.
Alger Fung, Chief Executive Officer of AIA Hong Kong & Macau, said: 'It is important for society to continue investing in better healthcare. It represents a growing share of our economy - and an even greater share of our hope for a sustainable and resilient future for all generations.
While Hong Kong's healthcare system is widely recognised for its professionalism, trust, and exceptional outcomes, it is facing increasing pressure from demographic shifts, medical inflation, and rising demand across both the public and private sectors.
As an insurer deeply rooted in Hong Kong, AIA is committed to supporting our society in overcoming these pressing challenges. We believe that meaningful change begins with collective action, guided by a shared sense of conscience and responsibility. Thanks to the valuable contributions of all participants, this Summit has brought together an alliance in action—marking the beginning of a shared journey towards building a more inclusive and sustainable healthcare system for our community and future generations.
Yet this is only the beginning. The future depends on the continued, purposeful actions of all stakeholders. Together, we can play a pivotal role in shaping a healthcare system that empowers people to live Healthier, Longer, Better Lives.'
Caption: Distinguished speakers, panelists and guests at the Healthcare Financing Summit hosted by AIA Hong Kong & Macau
Caption: The Healthcare Financing Summit bringing together government officials, legislators, regulators, and leaders from the healthcare and insurance industries to explore collaborative solutions for building a healthcare system that is accessible, affordable, and effective for the sustainable future of Hong Kong.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
a day ago
- Malay Mail
AIA Hosts Healthcare Financing Summit To Foster Cross-Sector Collaborative Solutions for Hong Kong's Healthcare Sustainable Future
Caption: Professor Chung-mau Lo, Secretary for Health of the Hong Kong Special Administrative Region Government (centre); Mr Clement Cheung Wan-ching, Chief Executive Officer of the Insurance Authority (right); and Mr Alger Fung, Chief Executive Officer of AIA Hong Kong & Macau (left), officiating the opening at the Healthcare Financing Summit Caption: Alger Fung, Chief Executive Officer of AIA Hong Kong & Macau, delivers the opening address, highlighting the importance of collaboration across sectors to build a more inclusive and sustainable healthcare system for the community and future generations. Caption: Alice Liang, Chief Proposition and Healthcare Officer of AIA Hong Kong & Macau, presents her topical address, 'Healthcare - Insurance Industry Experience', sharing data-driven observations and insights on the evolving role of insurers in shaping sustainable healthcare financing models. Caption: Distinguished speakers, panelists and guests at the Healthcare Financing Summit hosted by AIA Hong Kong & Macau Caption: The Healthcare Financing Summit bringing together government officials, legislators, regulators, and leaders from the healthcare and insurance industries to explore collaborative solutions for building a healthcare system that is accessible, affordable, and effective for the sustainable future of Hong Kong. HONG KONG SAR - Media OutReach Newswire - 4 July 2025 - AIA Hong Kong & Macau (AIA) hosted the inaugural Healthcare Financing Summit (the Summit) as an active step towards fostering cross-sector dialogue and collaboration to address the challenges facing Hong Kong's healthcare system. Held under the theme "Sustainable Healthcare Financing through Partnership", the Summit brought together a diverse group of stakeholders – including government officials, legislators, regulators, and leaders from the healthcare and insurance industries – to explore collaborative solutions for building a healthcare system that is accessible, affordable, and effective for the sustainable future of Hong event featured distinguished speakers, including Professor Chung-mau Lo, Secretary for Health of the Hong Kong Special Administrative Region Government, and Mr Clement Cheung Wan-ching, Chief Executive Officer of the Insurance Authority, who shared their insights on the future of Hong Kong's healthcare. Discussions focused on the growing challenges of rising healthcare costs, an ageing population, the critical needs to foster price transparency and budgeting for patients, clinical governance in private medical services, and how stakeholders can work together to ensure the long-term sustainability of Hong Kong's is important for society to continue investing in better healthcare. It represents a growing share of our economy - and an even greater share of our hope for a sustainable and resilient future for all Hong Kong's healthcare system is widely recognised for its professionalism, trust, and exceptional outcomes, it is facing increasing pressure from demographic shifts, medical inflation, and rising demand across both the public and private an insurer deeply rooted in Hong Kong, AIA is committed to supporting our society in overcoming these pressing challenges. We believe that meaningful change begins with collective action, guided by a shared sense of conscience and responsibility. Thanks to the valuable contributions of all participants, this Summit has brought together an alliance in action—marking the beginning of a shared journey towards building a more inclusive and sustainable healthcare system for our community and future this is only the beginning. The future depends on the continued, purposeful actions of all stakeholders. Together, we can play a pivotal role in shaping a healthcare system that empowers people to live Healthier, Longer, Better Lives."Hashtag: #AIA #友邦 The issuer is solely responsible for the content of this announcement. About AIA Hong Kong & Macau AIA Group Limited established its operations in Hong Kong in 1931. To date, AIA Hong Kong and AIA Macau have over 18,000 financial planners1, as well as an extensive network of independent financial advisors, brokerage and bancassurance partners. We serve over 3.6 million customers2, offering them a wide selection of professional services and products ranging from individual life, group life, accident, medical and health, pension, personal lines insurance to investment-linked assurance schemes with numerous investment options. We are also dedicated to providing superb product solutions to meet the financial needs of high-net-worth customers. as of 31 March 2025Including AIA Hong Kong and AIA Macau's individual life, group insurance and pension customers (as of 31 March 2025)
The Sun
a day ago
- The Sun
AIA Hosts Healthcare Financing Summit To Foster Cross-Sector Collaborative Solutions for Hong Kong's Healthcare Sustainable Future
HONG KONG SAR - Media OutReach Newswire - 4 July 2025 - AIA Hong Kong & Macau (AIA) hosted the inaugural Healthcare Financing Summit (the Summit) as an active step towards fostering cross-sector dialogue and collaboration to address the challenges facing Hong Kong's healthcare system. Held under the theme 'Sustainable Healthcare Financing through Partnership', the Summit brought together a diverse group of stakeholders – including government officials, legislators, regulators, and leaders from the healthcare and insurance industries – to explore collaborative solutions for building a healthcare system that is accessible, affordable, and effective for the sustainable future of Hong Kong. The event featured distinguished speakers, including Professor Chung-mau Lo, Secretary for Health of the Hong Kong Special Administrative Region Government, and Mr Clement Cheung Wan-ching, Chief Executive Officer of the Insurance Authority, who shared their insights on the future of Hong Kong's healthcare. Discussions focused on the growing challenges of rising healthcare costs, an ageing population, the critical needs to foster price transparency and budgeting for patients, clinical governance in private medical services, and how stakeholders can work together to ensure the long-term sustainability of Hong Kong's healthcare. Alger Fung, Chief Executive Officer of AIA Hong Kong & Macau, said: 'It is important for society to continue investing in better healthcare. It represents a growing share of our economy - and an even greater share of our hope for a sustainable and resilient future for all generations. While Hong Kong's healthcare system is widely recognised for its professionalism, trust, and exceptional outcomes, it is facing increasing pressure from demographic shifts, medical inflation, and rising demand across both the public and private sectors. As an insurer deeply rooted in Hong Kong, AIA is committed to supporting our society in overcoming these pressing challenges. We believe that meaningful change begins with collective action, guided by a shared sense of conscience and responsibility. Thanks to the valuable contributions of all participants, this Summit has brought together an alliance in action—marking the beginning of a shared journey towards building a more inclusive and sustainable healthcare system for our community and future generations. Yet this is only the beginning. The future depends on the continued, purposeful actions of all stakeholders. Together, we can play a pivotal role in shaping a healthcare system that empowers people to live Healthier, Longer, Better Lives.' Caption: Distinguished speakers, panelists and guests at the Healthcare Financing Summit hosted by AIA Hong Kong & Macau Caption: The Healthcare Financing Summit bringing together government officials, legislators, regulators, and leaders from the healthcare and insurance industries to explore collaborative solutions for building a healthcare system that is accessible, affordable, and effective for the sustainable future of Hong Kong.
The Sun
3 days ago
- The Sun
Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha
HONG KONG SAR - EQS Newswire - 2 July 2025 - On June 27, 2025, Uni-Bio Science Group Limited (the 'Group')grandly held a new medical aesthetics product launch event in Changsha, releasing the high-end series GeneQueens of 肌顏態® and the medical device brand 金因敷®. Many experts, KOLs and partners attended the event. This launch not only showcased the Group's achievements in R&D, but also marked the comprehensive layout in the 'drug, medical device and Aesthetics' field. 1、 High-end medical aesthetics: GeneQueens series At the launch, the Group unveiled the high-end series of 肌顏態® -——GeneQueensTM (Human-Sequence Triple Protein Repair & Balance Ampoule). which functions on skin repair and anti-aging. By activating cell regeneration, it helps users restore their youthful and healthy skin condition. GeneQueensTM sets a new standard for anti-aging and repair by adding three core ingredients in sufficient quantities. Skbrella FN, as a key ingredient for cell repair, can accelerate the healing of skin wounds and promote the adhesion and migration of new cells. III Collagen strongly fills the skin structure, significantly enhancing elasticity and firmness. XVII Collagen can strengthen the connection between the epidermis and dermis, and consolidate the youthful foundation of the skin. In addition, GeneQueens adopts a sterile and preservative-free formula, relying on high-purity raw materials and patented technology, providing users with an 'instant enjoyment' precise and efficient experience. Its unique formula and outstanding efficacy were highly recognized by many experts on the spot. 2、金因敷 showcased a variety of new products Meanwhile, the Group also launched several new products of its medical device brand - 金因敷®, focusing on the professional repair field of medical aesthetics. 金因敷® complies with strict clinical trials and quality inspections to ensure its safety and effectiveness. The product adopts a high-purity non-allergenic formula, which can moisturize and accelerate wound repair. It also uses an exclusive cooling technology to relieve postoperative swelling and pain, providing a professional solution for sensitive skin and post-medical procedure care. 3、The latest research data was presented at CSD2025 It is worth mentioning that 肌顏態® also showcased the research data of 'The Efficacy Study of Fibronectin in the Repair of Skin Barrier Damage for the post-medical procedure' jointly conducted with the Cosmetics Testing Center of the Dermatology Hospital of Southern Medical University in the poster area of the 30th Academic Conference of the Chinese Medical Association (CSD2025). This is not only an endorsement of the Group's research capabilities, but also provides experts and scholars in the industry with an opportunity to gain a deeper understanding of the 肌顏態® technology and products. As an annual grand event in the field of dermatology and venereology in China, CSD2025 brings together authoritative experts and scholars in dermatology across the country, presenting multi-dimensional academic achievements and exchanges of ideas. The poster area is one of the core venues of the academic annual conference. Posters are not only an important way for researchers to showcase their scientific research achievements, but also a key link in promoting the dissemination of academic ideas and the feedback of clinical practice. 4、Academic speeches by several experts Several clinical experts at the launch further recognized the significant clinical value of 肌顏態® and 金因敷®. The experts highlighted that 肌顏態®' s patented ingredient, Skbrella FN, demonstrates immense potential in improving damaged sensitive skin barriers, reducing inflammatory erythema, alleviating discomfort sensations such as burning, tightness and itching, as well as enhancing post-laser repair and healing. In the clinical observations over the past few months, many patients treated with 肌顏態® have achieved remarkable therapeutic effects. The symptoms of anesthetic allergy have been rapidly relieved, the inflammatory pigmentation post-laser has significantly improved, the skin barrier has been repaired, and the patient satisfaction rate is extremely high. 金因敷® can effectively reduce redness, swelling and pain for post-medical procedures, accelerate wound healing and shorten the recovery time. Photo 1: 肌顏態 use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University; Photo 2: 肌顏態 use case sharing by Professor Ge Lan, from The First Affiliated Hospital of Army Medical University; Photo 3: Fibronectin clinical trial results sharing by Professor Ye Li, Head of Cosmetics Testing Center at Dermatology Hospital of Southern Medical University; Photo 4: Mr. Du Wei, CEO of Cosmetics News & Cosmetics Business Online, analyzes cosmetics industry development trends 6、The signing ceremony reflects the market potential Mr. Zhao Zhigang, CEO of Uni-Bio Science Group, emphasized: ' We have always adhered to the standards of biopharmaceuticals in creating skin care products. The release of GeneQueens and 金因敷 is an important milestone in building the 'Drugs, Medical device and Aesthetics' strategy and creating a full-cycle skin care solution, aiming to meet consumers' increasingly refined skin health needs. ' Furthermore, Ms. Liu Yihua, President of Global Cosmetics Group, attended the launch as an important guest. Uni-Bio Science Group and Global Cosmetics Group have jointly established a medical research co-creation biological platform. Utilizing gene-editing biosynthesis technology, the platform has launched Skbrella FN – a highly bioactive recombinant human fibronectin known as '皮優理'. The launch also witnessed a grand strategic signing ceremony. The Group has achieved in-depth cooperation with many well-known medical aesthetics chain institutions and well-known agents. This signing is not only a high recognition of the quality and market potential of GeneQueens and 金因敷®, but also a key step for the Group to accelerate commercialization and expand channels. Through strong alliances with leading channel partners, the Group will reach the core consumers and ensure the rapid release of huge commercial value. The successful holding of this launch not only marks a crucial step for the Group in medical aesthetics and medical devices, but also demonstrates the Group's in-depth layout and forward-looking vision in the 'Drugs, Medical device and Aesthetics' strategy. In the future, the Group will continue to be guided by technology and oriented towards clinical value, accelerate product innovation and technological upgrading, constantly enrich pipeline, and meet the growing market demands.
